Patent · US Active

Peanut formulations and uses thereof

US9492535B2 · kind B2 · utility

13Cited by
1References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2014
Grant dateNov 15, 2016
Priority date
Expiry dateMar 12, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.